Owner Abbott Biotechnology Ltd

Inventors Roberts, Andrew J; Allen, Deborah J; Sakorafas, Paul; Vaughan, Tristan J; Kaymakcalan, Zehr; White, Michael; Labkovsky, Boris; Schoenhaut, David; Salfeld, Jochen G; McGuiness, Brian T; Mankovich, John A; Hoogenboom, Hendricus R J M; Wilton, Alison J

Agent Shelston IP

Pub. Number AU-B-2004202769

Parent 66649

Filing date 23 June 2004

Wipo publication date 15 July 2004

Acceptance publication date 31 August 2006

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/64 (2006.01) Mutation or genetic engineering - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids